| Literature DB >> 22154375 |
Hideaki Nakatsuji1, Ken Kishida, Tohru Funahashi, Iichiro Shimomura.
Abstract
We measured circulating S100A8/A9 (MRP8/14) complex levels before and after 3-month treatment with pioglitazone in type 2 diabetic patients. The results showed that pioglitazone reduced circulating S100A8/A9 complex levels, without changing body mass index, in type 2 diabetic patients with abdominal obesity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22154375 DOI: 10.1016/j.diabres.2011.11.018
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN: 0168-8227 Impact factor: 5.602